Amicus Therapeutics, Inc.
FOLD
$7.61
$0.010.13%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -38.10M | -29.37M | -56.11M | -104.69M | -119.54M |
Total Depreciation and Amortization | 7.90M | 8.23M | 8.55M | 8.69M | 8.75M |
Total Amortization of Deferred Charges | 2.41M | 2.34M | 2.26M | 2.20M | 2.35M |
Total Other Non-Cash Items | 92.89M | 92.98M | 110.35M | 121.79M | 109.82M |
Change in Net Operating Assets | -110.76M | -70.62M | -98.94M | -54.51M | -43.27M |
Cash from Operations | -45.66M | 3.56M | -33.89M | -26.52M | -41.89M |
Capital Expenditure | -3.26M | -1.95M | -3.55M | -5.00M | -6.21M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -21.50M | -39.00M | 2.99M | 871.00K | 3.57M |
Cash from Investing | -24.76M | -40.96M | -560.00K | -4.13M | -2.63M |
Total Debt Issued | -- | -- | -- | 387.36M | 387.36M |
Total Debt Repaid | -42.00K | -70.00K | -97.00K | -408.29M | -408.35M |
Issuance of Common Stock | 23.07M | 23.89M | 27.24M | 57.52M | 76.56M |
Repurchase of Common Stock | -15.84M | -17.09M | -22.03M | -22.76M | -22.32M |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -1.59M | -1.59M |
Cash from Financing | 7.19M | 6.73M | 5.12M | 12.23M | 31.66M |
Foreign Exchange rate Adjustments | 12.89M | 2.60M | -4.03M | -11.04M | 10.89M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -50.34M | -28.06M | -33.36M | -29.45M | -1.98M |